Onkologia Medikoa
Espezialitatea
Institut d'Investigació Biomédica de Bellvitge
Barcelona, EspañaInstitut d'Investigació Biomédica de Bellvitge -ko ikertzaileekin lankidetzan egindako argitalpenak (22)
2023
-
Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes
The Lancet. Oncology, Vol. 24, Núm. 1, pp. 91-106
2022
-
Prediction of chemotoxicity, unplanned hospitalizations and early death in older patients with colorectal cancer treated with chemotherapy
Cancers, Vol. 14, Núm. 1
-
Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy
Journal for immunotherapy of cancer, Vol. 10, Núm. 9
2021
-
Clinical and molecular parameters associated to pneumonitis development in non-small-cell lung cancer patients receiving chemoimmunotherapy from NADIM trial
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 8
-
Development and validation of an early mortality risk score for older patients treated with chemotherapy for cancer
Journal of Clinical Medicine, Vol. 10, Núm. 8
-
Undertreatment and overtreatment in older patients treated with chemotherapy
Journal of Geriatric Oncology, Vol. 12, Núm. 3, pp. 381-387
2020
-
Predicting Chemotherapy Toxicity in Older Patients with Cancer: A Multicenter Prospective Study
Oncologist, Vol. 25, Núm. 10, pp. e1516-e1524
2019
-
Efficacy and safety of dasatinib with trastuzumab and paclitaxel in first line HER2-positive metastatic breast cancer: results from the phase II GEICAM/2010-04 study
Breast Cancer Research and Treatment, Vol. 174, Núm. 3, pp. 693-701
-
Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients
Aging, Vol. 11, Núm. 9, pp. 2874-2888
2018
-
A risk-adapted approach to patients with stage i seminoma according to the status of rete testis: The fourth Spanish germ cell cancer group study
Oncology (Switzerland), Vol. 95, Núm. 1, pp. 8-12
2017
-
Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population
Stem Cell Reports, Vol. 8, Núm. 5, pp. 1392-1407
2015
-
FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies
Oncotarget, Vol. 6, Núm. 42, pp. 44254-44273
2014
-
VAV3 mediates resistance to breast cancer endocrine therapy
Breast Cancer Research, Vol. 16, Núm. 3
2012
-
RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis
Cancer Research, Vol. 72, Núm. 11, pp. 2879-2888
2011
-
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines
Breast Cancer Research, Vol. 13, Núm. 6
-
Evidence for a link between TNFRSF11A and risk of breast cancer
Breast Cancer Research and Treatment, Vol. 129, Núm. 3, pp. 947-954
-
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer
PLoS Biology, Vol. 9, Núm. 11
2010
-
Avoiding axillary treatment in sentinel lymph node micrometastases of breast cancer: A prospective analysis of axillary or distant recurrence
Annals of Surgical Oncology, Vol. 17, Núm. 3, pp. 772-777
-
Biological reprogramming in acquired resistance to endocrine therapy of breast cancer
Oncogene, Vol. 29, Núm. 45, pp. 6071-6083
-
Novel anti-fatty acid synthase compounds with anti-cancer activity in HER2+ breast cancer
Annals of the New York Academy of Sciences, Vol. 1210, Núm. 1, pp. 86-92